Furthermore, to evaluate how cancer-associated variants affect protein–protein or protein–mRNA networks, we systematically analyzed the mutations in core NMD components (eRF1, EIF4A3, and SMG1; Figure 1). The gene discussed is PLA1A; the disease is cancer.